These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 883988)

  • 1. Inhibition by beta-endorphin of dopamine-sensitive adenylate cyclase in rat striatum.
    Motomatsu T; Lis M; Seidah N; Chrétien M
    Biochem Biophys Res Commun; 1977 Jul; 77(1):442-7. PubMed ID: 883988
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid inhibition of adenylate cyclase in the striatum and vas deferens of the rat.
    Bhoola KD; Pay S
    Br J Pharmacol; 1986 Sep; 89(1):109-18. PubMed ID: 3026542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase.
    Law PY; Wu J; Koehler JE; Loh HH
    J Neurochem; 1981 May; 36(5):1834-46. PubMed ID: 7241139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
    Thomas TN; Zemp JW
    J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
    [No Abstract]   [Full Text] [Related]  

  • 5. The absence of sodium ions does not explain the failure of sulpiride to inhibit, in vitro, rat striatal dopamine-sensitive adenylate cyclase.
    Rupniak NM; Jenner P; Marsden CD
    J Pharm Pharmacol; 1981 Sep; 33(9):602-3. PubMed ID: 6117643
    [No Abstract]   [Full Text] [Related]  

  • 6. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
    Karobath M; Leitich H
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic antidepressive drugs and dopamine-sensitive adenylate cyclase from rat brain striatum.
    Karobath ME
    Eur J Pharmacol; 1975 Feb; 30(2):159-63. PubMed ID: 1126356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum.
    Laduron P; Verwimp M; Janssen PF; Leysen J
    Life Sci; 1976 Feb; 18(4):433-9. PubMed ID: 130527
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of adenylate cyclase by tetraplatin.
    Ho BT; Huo YY; Lee JH; Levin VA
    Anticancer Drugs; 1991 Jun; 2(3):267-8. PubMed ID: 1802021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
    Marshall AM; Ramwani J; Mishra RK
    Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.
    Nakahara T; Uchimura H; Saito M; Hirano M; Kim JS; Ito M
    J Neurochem; 1978 Nov; 31(5):1335-7. PubMed ID: 702178
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary.
    Schmidt MJ; Hill LE
    Life Sci; 1977 Mar; 20(5):789-97. PubMed ID: 15714761
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine.
    Walton KG; Liepmann P; Baldessarini RJ
    Eur J Pharmacol; 1978 Nov; 52(2):231-4. PubMed ID: 729635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol does not modify opiate-mediated inhibition of striatal adenylate cyclase.
    Hoffman PL; Tabakoff B
    J Neurochem; 1986 Mar; 46(3):812-6. PubMed ID: 3512771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.
    Karobath ME
    Eur J Pharmacol; 1974 Oct; 28(2):376-8. PubMed ID: 4424404
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of inhibitory actions of chlorpromazine or its 7,8-dihydroxy and 7,8-dioxo-didesmethyl analogs on DA-sensitive adenylate cyclase and calmodulin activation of phosphodiesterase in rat striatum.
    Palmer GC; Pajer KA; Manian AA
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):202-11. PubMed ID: 2988471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
    Prémont J; Tassin JP; Thierry AM; Bockaert J
    Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post mortem changes in adenylate cyclase activity in rat brain striatum.
    Witte P; Matthaei H
    Experientia; 1979 Nov; 35(11):1421-2. PubMed ID: 510461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting factors in the antagonism of neuroleptics on dopamine-sensitive adenylate cyclase.
    Laduron P
    J Pharm Pharmacol; 1976 Mar; 28(3):250-1. PubMed ID: 6703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.